Skip to main navigation
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us
Aerovate Therapeutics

SEC Filing Details

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us

SEC Filing Details

Document Details

Form
4
Filing Date
October 12, 2022
Document Date
October 10, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Aerovate Therapeutics, Inc.
Issuer
Aerovate Therapeutics, Inc.
Filer
DAKE BENJAMIN T

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us
Aerovate Therapeutics
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us

© 2023 Aerovate Therapeutics, Inc. All Rights Reserved. | Privacy Policy | Terms of Use